Drug profile · INN
phendimetrazine tartrate
METRA
phendimetrazine tartrate (METRA) is a norepinephrine transporter inhibitor. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
Drug details — phendimetrazine tartrate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
phendimetrazine tartrate (METRA) is a norepinephrine transporter inhibitor. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Sodium-dependent dopamine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is phendimetrazine tartrate?
phendimetrazine tartrate (METRA) is a norepinephrine transporter inhibitor. Associated with ELITE PHARMACEUTICALS INC /NV/. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for phendimetrazine tartrate?
METRA is a marketed brand name for phendimetrazine tartrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of phendimetrazine tartrate?
phendimetrazine tartrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.